China Shineway Pharmaceutical Group Limited (FRA:C1S)
Germany flag Germany · Delayed Price · Currency is EUR
1.020
-0.010 (-0.97%)
Last updated: Jan 27, 2026, 9:55 AM CET

FRA:C1S Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
6,8616,1405,8895,0264,2063,943
Short-Term Investments
-4.484.023.694.325.32
Trading Asset Securities
100.42350.022020.23--
Cash & Short-Term Investments
6,9616,4955,9135,0504,2103,948
Cash Growth
11.65%9.84%17.08%19.96%6.63%-0.52%
Accounts Receivable
1,1921,2021,260975.06825.18760.66
Other Receivables
-66.8163.9267.4840.8723.07
Receivables
1,1921,2691,3241,043866.05783.73
Inventory
722.37813.19897.71657.66587.96443
Other Current Assets
77.22219.9432.0135.06343.99
Total Current Assets
8,9538,5998,1556,7825,6995,519
Property, Plant & Equipment
1,2251,2191,2051,2171,2521,395
Goodwill
165.96165.96165.96165.96165.96102.5
Other Intangible Assets
18.9123.3232.7947.3566.4336.96
Long-Term Deferred Tax Assets
24.7334.3315.2319.2220.4723.1
Other Long-Term Assets
-----137.14
Total Assets
10,38810,0429,5748,2327,2047,214
Accounts Payable
377.68402.96484.79308.75228.62164.38
Accrued Expenses
13.781,1991,121856.76483.21319.13
Short-Term Debt
300330300--369.32
Current Portion of Leases
8.518.270.976.537.597.79
Current Income Taxes Payable
68.8984.27105.91107.7965.158.37
Current Unearned Revenue
103.31101.75127.4165.22117.0578.42
Other Current Liabilities
1,556323.67294.13220.54196.81197.28
Total Current Liabilities
2,4282,4502,4341,6661,0981,195
Long-Term Leases
4.358.260.360.917.3215.03
Long-Term Unearned Revenue
105.5781.8588.89163.99171.59204.31
Long-Term Deferred Tax Liabilities
11.5634.5216.2618.8425.195.3
Total Liabilities
2,5782,5752,5391,8491,3021,419
Common Stock
87.6687.6687.6687.6687.6687.66
Additional Paid-In Capital
422.14422.14422.14422.14422.14422.14
Retained Earnings
7,7957,4527,0206,3685,8795,778
Comprehensive Income & Other
-494.89-494.89-494.89-494.89-487.32-493.42
Total Common Equity
7,8107,4677,0356,3835,9015,794
Shareholders' Equity
7,8107,4677,0356,3835,9015,794
Total Liabilities & Equity
10,38810,0429,5748,2327,2047,214
Total Debt
341.34346.53301.337.4414.91392.14
Net Cash (Debt)
6,6206,1485,6115,0434,1953,556
Net Cash Growth
12.51%9.56%11.28%20.21%17.97%-0.23%
Net Cash Per Share
8.768.147.436.685.564.70
Filing Date Shares Outstanding
755.4755.4755.4755.4755.4754.6
Total Common Shares Outstanding
755.4755.4755.4755.4755.4754.6
Working Capital
6,5256,1495,7215,1174,6014,324
Book Value Per Share
10.349.889.318.457.817.68
Tangible Book Value
7,6257,2786,8366,1695,6695,655
Tangible Book Value Per Share
10.099.639.058.177.507.49
Machinery
-1,4941,4891,4381,3921,388
Construction In Progress
-195.51117.68193.06130.17115.5
Source: S&P Global Market Intelligence. Standard template. Financial Sources.